News

ArborGen has released its unaudited results for the six months ended 30 September 2024. All dollar values are in US currency unless otherwise stated.

ArborGen is pleased to announce that it has signed a memorandum of understanding to acquire the Eco Empreendimentos nursery in Piauí, Brazil, for approximately USD$2.5m, which will utilize seller financing and cash already in Brazil to fund the transaction.

ArborGen has today provided an update on the impact of Hurricane Helene on its orchards in Georgia, USA.

ArborGen Holdings Limited (NZX: ARB) advises that it has commenced the on-market share buyback with a maximum of 6,500,000 ordinary shares to return capital of up to US$500,000.

ArborGen advises that, effective from today, Grant Thornton has been appointed as ArborGen’s external auditor.

At ArborGen Holdings Limited’s shareholder meeting, held in Auckland today, shareholders were asked to vote on 4 resolutions, which were supported by the Board. All resolutions were passed.

ArborGen announces that it intends to commence an on-market share buyback of ordinary shares to return capital of up to US$500,000. The buyback may occur from 2 September 2024.

ArborGen Holdings Limited advises that it has now completed the sale of its in vitro services business for USD$4 million. The proceeds will be used to pay down debt and allow for investment into growth and productivity opportunities.

ArborGen Holdings Limited has today announced its results for the financial year ending 31 March 2024 (FY24), reporting record sales Revenue and an Adjusted US GAAP EBITDA result ahead of guidance.

9 April 2024 - ArborGen Holdings Limited advises that, based on unaudited preliminary management accounts, its net debt as at 31 March 2024 is now expected to be 25% to 35% lower than previously advised.

ArborGen is pleased to advise the appointment of Christina Green as Chief Financial Officer. Christina will commence the role from 25 March 2024 and will be based in ArborGen’s head office in Ridgeville, South Carolina.

ArborGen has today released its interim results for the six months ended 30 September 2023 (1H24), reporting a strong first half financial performance driven by record sales volumes in Brazil. Guidance for FY24 has been revised, with US seedling sales now expected to be lower than originally anticipated.

ArborGen Holdings Limited (NZX: ARB) (the Company) advises that its Company Secretary and Performance Improvement Director, Sharon Ludher-Chandra, will be stepping down from her role with the Company on 31 October 2023 to pursue other opportunities, including her role with Tenon Clearwood.

ArborGen advises details of the voting which resulted in all resolutions being passed at its Annual Shareholders' Meeting on 20 September 2023.

ArborGen Holdings Limited advises it has acquired a eucalyptus seedlings nursery operation in Brazil located in the town of Erval Grande in Rio Grande do Sul State, referred to as Grande.

ArborGen advises Adriano E. Amaral de Almeida will assume the role of General Manager of its Brazil operations.

ArborGen Holdings Limited (NZX: ARB) advises that the closing date for director nominations is Tuesday 8 August 2023.

ArborGen Holdings Limited (NZX: ARB) (the Company) announces Justin Birch will assume the roles of Chief Executive Officer (CEO) of the Company and of the Company’s wholly owned US based subsidiary, ArborGen Inc. (ArborGen), effective 16 June 2023 US time.

ArborGen Holdings Limited (NZX:ARB) is pleased to advise that the company’s Annual Shareholder Meeting will be held at the Ellerslie Event Centre in Auckland in the Remuera Room, on Wednesday 20th of September 2023.

ArborGen Holdings has reported its audited results for the 12 months ended 31 March 2023 (FY23)1, with an 18% increase in group revenues to US$56.1 million, and a US$3.5 million increase in operating profit to US$2.2 million. ArborGen also reported a 35% increase in US-GAAP EBITDA2,3 to US$10.3 million in FY23, and positive commercial progress under its new strategy.

ArborGen Holdings advises that its wholly owned subsidiary, ArborGen Inc, has negotiated the repurchase of all outstanding warrants, which equates to approximately 5% of ArborGen Inc.’s fully diluted common stock.

ArborGen Holdings Limited is pleased to announce the appointment of Justin Birch as President and Chief Executive Officer (CEO) of ArborGen Inc. (ArborGen) effective 19 June 2023, or earlier. Mr Birch’s appointment follows a comprehensive and extensive search process.

ArborGen Holdings Limited advises that its Chief Executive Officer, Andrew Baum, will be
stepping down from his role with the company as CEO once a successor has been recruited. Upon the
hiring of a new CEO, Andrew will remain in a consulting role to the business to ensure a smooth
leadership transition.

The Board is pleased to present the Interim Report for the six months ended 30 September 2022.

ArborGen Holdings Limited (NZX: ARB) announces today that its wholly owned subsidiary in the US, ArborGen Inc., has completed extensive analysis confirming it should be entitled it to receive US$2 million of Employee Retention Credits under the Coronavirus Aid Relief and Economic Security (CARES) Act.

ArborGen advises details of the voting which resulted in all resolutions being passed at its Annual Shareholders' Meeting on 24 August 2022.

Pursuant to NZX Listing Rule 3.20.1(a), ArborGen Holdings Limited (“ArborGen” or the “Company”) advises that Ranjan Tandon has notified the Company that he will resign from the ArborGen Board effective 30 June 2022.

ArborGen is pleased to advise that the company’s Annual Shareholder Meeting will be held at the Ellerslie Event Centre in Auckland in the Remuera Room, on Wednesday 24th of August 2022 at 10:00am.

ArborGen is pleased to advise that the company’s Annual Shareholder Meeting will be held at the Ellerslie Event Centre in Auckland in the Remuera Room, on Wednesday 24th of August 2022 at 10:00am.

ArborGen Holdings Limited (NZX: ARB) advises that the closing date for director nominations is 4 July
2022.

ArborGen Holdings Limited (NZX: ARB) (the “Company” or “ArborGen”) announces today that as a result of the strategic review conducted over the last year, the Board of ArborGen has refocussed the business on its core traditional and emerging high growth markets in the US South and Brazil, as well as on new and emerging high growth carbon markets.

Pleasing results and strong advanced genetics sales growth as ArborGen focuses on growth markets

ArborGen announced today that a freeze event combined with very high winds during this year’s MCP pollination season has caused damage to pine flowers at its Coastal orchards. ArborGen’s western orchards were not impacted.

In November 2021, ArborGen Holdings Limited (NZX: ARB) (the Company) announced guidance of US GAAP EBITDA in the range of US$11.3 to $11.7 million for the fiscal year ending 31 March 2022 (FY22) subject to any future impact from supply chain and COVID related issues in the US. Since then the pandemic, including the recent emergence of Omicron, is continuing to cause significant disruptions in the industry ranging from transportation issues to labour shortages.

ArborGen Holdings Limited (NZX: ARB) (the Company or ArborGen) announced today that following completion of the sale of ArborGen’s New Zealand and Australian businesses for NZ$22.25 million (the ANZ Transaction), it has repaid the US$2.88 million of sub-ordinated debt raised in 2019 from certain directors / major shareholders and senior management needed to fund the US$14.4 million acquisition of ArborGen’s headquarters in Ridgeville, South Carolina.

As announced on 1 November 2021 ArborGen Holdings Limited entered into an agreement to sell ArborGen’s New Zealand and Australian businesses to ArborGen ANZ Limited Partnership (previously Geyser Limited Partnership) for NZ$22.25 million (the ANZ Transaction).

ArborGen Holdings Limited (NZX: ARB) has announced its unaudited results for the six months to 30
September 2021, reporting a period of positive revenue and earnings growth in its US and Brazil markets.

As announced on 1 November 2021 (https://www.nzx.com/announcements/381921), ArborGen Holdings Limited (NZX: ARB) (the Company or ArborGen) has entered into an agreement to sell ArborGen’s New Zealand and Australian businesses (ArborGen ANZ) for NZ$22.25m to Geyser Limited Partnership (since renamed ArborGen ANZ Limited Partnership (the Purchaser)).

​

An agreement has been entered into for the sale of ArborGen’s New Zealand and Australian
businesses (ArborGen ANZ) for NZ$22.25m in cash, with settlement scheduled for 30 November 2021.

ArborGen Holdings Limited (NZX: ARB) (the Company) announced that, as mentioned at the Company’s
August 2021 Annual Shareholders Meeting, extreme rain conditions during the early, most vulnerable,
phase of seedling growth, resulted in early season seedling inventory losses in the current production year.

ArborGen advises details of the voting which resulted in all resolutions being passed at its Annual Shareholders' Meeting on 19 August 2021.

The 2021 Annual Shareholders’ Meeting of ArborGen Holdings Limited (ARB) “ArborGen” is being held Thursday 19 August 2021, and was scheduled to be both a physical in-person and online meeting. Due to the New Zealand alert level 4 lockdown announcement, the meeting will now be an online (virtual) meeting only. Shareholders will not be able to attend the meeting in-person and this possibility was signalled in the notice of meeting.

Following confirmation that the first (US$2.3 million) loan received under the CARES Act Paycheck Protection Program has been forgiven, ArborGen Holdings today issued 1,493,076 new shares in relation to its FY2021 Long Term Incentive (2021 LTI) Plan.

Global advanced genetics seedling company, ArborGen Holdings Limited (NZX:ARB) (ArborGen or the Company) advises that the Company has received a confidential, non‐binding, indicative, incomplete and highly conditional proposal from a credible third party to acquire all of the shares in, or assets of, ArborGen by way of a scheme of arrangement or other alternative acquisition structure (the Proposal).

Global advanced genetics seedling company, ArborGen Holdings Limited (NZX: ARB) has advised the first loan received from the Small Business Administration (SBA) under the CARES Act Paycheck Protection Program (PPP), of US$2.335 million, has now been completely forgiven.

ArborGen Holdings Limited (NZX: ARB) advises that the closing date for director nominations is 21 June 2021.

ArborGen Holdings Reports US$3.2m Net Profit, Projects Increasing Advanced Genetics Sales

For the 12 months ended 31 March 2021

​

​

Global advanced genetics seedling company, ArborGen Holdings Limited (NZX: ARB) has advised of an uplift in the Company’s earnings guidance.

ArborGen Holdings announced today that its wholly owned subsidiary in the US, ArborGen Inc., has received approval and funding from the Small Business Administration (SBA) under the CARES Act Paycheck Protection Program (PPP) for a second loan in the amount of US$1.95 million.

To keep the market updated in the current environment, ArborGen Holdings announced today that confirmed sales orders in its largest market, the United States, currently represent around 92% of forecast US seedling revenues for the year.

In accordance with the provisions of an Executive Fixed Trading Plan (Plan), ArborGen Holdings today issued 216,347 new shares to Andrew Baum (CEO).

ArborGen Holdings (ArborGen) announced today the renegotiation and extension of its revolving credit facility agreement with Synovus Financial Corporation (Synovus) relating to a $17 million letter of credit (LOC) facility in the US.

Today, ArborGen, a world leader in the development and commercialisation of technologies that improve the productivity of trees, announced that it has entered into an agreement with Vallourec S.A. that gives ArborGen exclusive rights to develop and commercialise Vallourec’s genetically improved eucalyptus clones in Brazil.

In accordance with a provisions of both the 2018 and 2019 Non-Executive Director’s Share Plans, approved by shareholders on 17 September 2018 and 17 September 2019 respectively, the following shares have vested - 185,117 shares vested to each of the three Directors (Tom Avery, Ozey Horton and Paul Smart) under the 2018 share plan and 273,666 vested to George Adams under the 2019 share plan.

ArborGen announced that all resolutions were passed at its Annual Shareholders' Meeting today.

ArborGen Holdings Limited (ArborGen) is pleased to advise that the company’s Annual Shareholder Meeting will be reconvened on Wednesday 26th of August at 10.30am (NZ time). As advised, for the health and safety of our shareholders this will be a virtual meeting only.

ArborGen Holdings Limited (ArborGen) is pleased to advise that the company’s Annual Shareholder Meeting will now be reconvened on Wednesday 26th of August at 10.30am (NZ time), however for the health and safety of our shareholders this will be a virtual meeting only.

ArborGen Holdings Limited (ArborGen) announced today that the Annual Meeting of Shareholders of ArborGen scheduled for 10.30am Tuesday 18 August 2020 (NZ time) will be adjourned to a time and date to be advised.

This Release outlines our performance for the twelve month period to 31 March 2020, and our longer-term assessment for the Company.

ArborGen Holdings announced today that its wholly owned subsidiary in the US, ArborGen Inc, has received approval and funding in the amount of US$2.35 million from the US Small Business Administration (SBA) under the Paycheck Protection Program (PPP)

Expansion of Brazil Operations, COVID-19 and General Update

In order to keep the market fully informed, ArborGen Holdings today announced that, in compliance with the New Zealand Government’s Level 4 Alert status, its nursery operations in New Zealand would be closing from midnight tonight.